Health

FDA panel advises against black-box warning for ADHD drugs

NEWS IN BRIEF — Posted April 17, 2006

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

A Food and Drug Administration advisory panel decided March 22 against recommending that a black-box warning be placed on labels for several stimulant drugs often prescribed for children and adults with attention-deficit/hyperactivity disorder. Although certain adverse events were identified by the committee, most notably hallucinations and psychotic episodes, the risk level did not rise to the need for a black-box warning, said Robert Nelson, MD, PhD, chair of the Pediatric Advisory Committee and attending intensivist at Children's Hospital of Philadelphia.

The FDA's Drug Safety and Risk Management Advisory Committee had recommended in February that a black-box warning for cardiovascular risk be placed on such drugs as Adderall, Ritalin and Concerta. While a warning of possible heart risks posed by the medications was considered, the pediatric committee ultimately decided stimulants pose a lower risk for most younger patients than for adults.

Because the FDA is changing the way medication labels are organized to highlight important safety considerations, necessary precautions could likely be taken care of in the re-ordered labels, said Dr. Nelson.

A guide to help parents understand the risks posed by the drugs likely will be forthcoming, said Robert Temple, MD, director of FDA's drug evaluation center's Office of Medical Policy. The FDA will determine whether a black-box warning is appropriate.

Note: This item originally appeared at http://www.ama-assn.org/amednews/2006/04/17/hlbf0417.htm.

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

■ Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

■ American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

■ Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

■ The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

■ The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

■ Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

■ Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

■ When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn